Keyphrases
Inflammation
36%
Aging
32%
Cholesterol Accumulation
32%
GSDIa
32%
Cardiovascular Disease
32%
Cholesterol Efflux
32%
Glycogen Storage Disease Type II (GSDII)
32%
Mouse Model
32%
T Cells
32%
Interleukin-6
32%
Catabolic
32%
Production Rate
32%
Interleukin-18 (IL-18)
32%
Level Dependence
32%
Apolipoprotein(a)
32%
Pre-diabetes (pre-DM)
32%
Neutrophil Count
32%
Advanced Glycation End Products
32%
Skin Autofluorescence
32%
Monocyte Count
32%
Blood Neutrophils
32%
Blood Monocytes
32%
High-density Lipoprotein Cholesterol (HDL-C)
26%
Atherogenesis
24%
Lipoproteins
18%
Severe Hypertriglyceridemia
16%
Plasma Parameters
14%
Hematopoietic Stem Cells
13%
Race-ethnicity
13%
Atherosclerotic Cardiovascular Disease (ASCVD)
13%
T Cell Activation
12%
Macrophages
10%
Foam Cells
10%
Mendelian Randomization
10%
Diabetes
9%
Atherosclerotic Plaque
9%
Anti-atherogenic Effect
9%
Plasma Lipoproteins
9%
Population-based Cohort
8%
T-cell Fate
8%
Carbohydrate Metabolism
8%
Inborn Errors
8%
Patient Cohort
8%
Cardiovascular Risk
7%
Male Sex
6%
Inflammatory Genes
5%
Cholesterol Transporter
5%
Disease Case
5%
Clinical Trials
5%
Low Expression
5%
Immunology and Microbiology
Atherosclerosis
100%
Foam Cell
32%
T Cell
32%
Mouse
32%
Macrophage
32%
Mouse Model
32%
Monocyte Count
32%
Autofluorescence
32%
Glycation
32%
Population
32%
Neutrophil Count
32%
Carbohydrate Metabolism
16%
Hematopoietic Stem Cell
16%
Blood Plasma
16%
High Density Lipoprotein Cholesterol Level
16%
Upregulation
10%
Inflammasome
8%
Blood Level
8%
T Cell Activation
6%
Medicine and Dentistry
Atherosclerosis
64%
Effusion
36%
Middle Age
32%
T Cell
32%
Programmed Cell Death
32%
Smooth Muscle Cell
32%
Bladder Distension
32%
LDL Receptor
10%
T Cell Activation
6%
Vasoconstriction
6%
